78 related articles for article (PubMed ID: 25563327)
1. A case with ZNF198-FGFR1 gene rearrangement presenting as acute eosinophil myeloid leukemia.
Chao H; Zhou M; Zhang R
Chin Med J (Engl); 2015 Jan; 128(1):131-2. PubMed ID: 25563327
[No Abstract] [Full Text] [Related]
2. ZMYM2-FGFR1 fusion as secondary change in acute myeloid leukemia.
Cao M; Carrasco RD; Dubuc AM; Dal Cin P; Fletcher JA; Xiao S
Leuk Lymphoma; 2019 Feb; 60(2):556-558. PubMed ID: 30160587
[No Abstract] [Full Text] [Related]
3. B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.
Trimaldi J; Carballido EM; Bowers JW; Anguiano AL; Zhang ZJ; Shah BD; Bruno S; List AF; Moscinski LC; Grady T; Agosti SJ; Kang L; Zhang L
Acta Haematol; 2013; 130(3):127-34. PubMed ID: 23594707
[TBL] [Abstract][Full Text] [Related]
4. Submicroscopic deletion of FGFR1 gene is recurrently detected in myeloid and lymphoid neoplasms associated with ZMYM2-FGFR1 rearrangements: a case study.
Yang JJ; Park TS; Choi JR; Park SJ; Cho SY; Jun KR; Kim HR; Lee JN; Oh SH; Lee S; Kim B; Marschalek R; Meyer C
Acta Haematol; 2012; 127(2):119-23. PubMed ID: 22236811
[No Abstract] [Full Text] [Related]
5. HSPA1A is an important regulator of the stability and function of ZNF198 and its oncogenic derivative, ZNF198-FGFR1.
Kasyapa CS; Kunapuli P; Cowell JK
J Cell Biochem; 2007 Dec; 102(5):1308-17. PubMed ID: 17471537
[TBL] [Abstract][Full Text] [Related]
6. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.
Zhang WW; Habeebu S; Sheehan AM; Naeem R; Hernandez VS; Dreyer ZE; López-Terrada D
J Pediatr Hematol Oncol; 2009 Nov; 31(11):879-83. PubMed ID: 19829149
[TBL] [Abstract][Full Text] [Related]
7. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder.
Etienne A; Gelsi-Boyer V; Carbuccia N; Adélaïde J; Barba G; La Starza R; Murati A; Eclache V; Birg F; Birnbaum D; Mozziconacci MJ; Mecucci C; Chaffanet M
Cancer Genet Cytogenet; 2007 Mar; 173(2):154-8. PubMed ID: 17321332
[TBL] [Abstract][Full Text] [Related]
8. Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.
Kasyapa CS; Kunapuli P; Hawthorn L; Cowell JK
Blood; 2006 May; 107(9):3693-9. PubMed ID: 16410451
[TBL] [Abstract][Full Text] [Related]
9. Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene.
Mayeur-Rousse C; Sorel N; Voldoire M; Canioni D; Brizard F; Randriamalala E; Turhan AG; Chomel JC
Leuk Res; 2012 Mar; 36(3):377-81. PubMed ID: 22030335
[No Abstract] [Full Text] [Related]
10. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
Xiao S; Nalabolu SR; Aster JC; Ma J; Abruzzo L; Jaffe ES; Stone R; Weissman SM; Hudson TJ; Fletcher JA
Nat Genet; 1998 Jan; 18(1):84-7. PubMed ID: 9425908
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the SSBP2 and ABL proteins by the ZNF198-FGFR1 fusion kinase seen in atypical myeloproliferative disorders as revealed by phosphopeptide-specific MS.
Kasyapa C; Gu TL; Nagarajan L; Polakiewicz R; Cowell JK
Proteomics; 2009 Aug; 9(16):3979-88. PubMed ID: 19658100
[TBL] [Abstract][Full Text] [Related]
12. Marked thrombocytosis and dysmegakaryopoiesis in acute myeloid leukemia with t(2;3)(p22;q26.2) and EVI1 rearrangement.
Yamamoto K; Okamura A; Sanada Y; Yakushijin K; Matsuoka H; Minami H
Ann Hematol; 2013 Dec; 92(12):1713-5. PubMed ID: 23604431
[No Abstract] [Full Text] [Related]
13. Acute leukemia with cytogenetically cryptic FGFR1 rearrangement and lineage switch during therapy: A case report and literature review.
McKeague SJ; O'Rourke K; Fanning S; Joy C; Throp D; Adams R; Harvey Y; Keng TB
Am J Clin Pathol; 2024 Feb; 161(2):197-205. PubMed ID: 37855739
[TBL] [Abstract][Full Text] [Related]
14. A model of BCR-FGFR1 driven human AML in immunocompromised mice.
Cowell JK; Qin H; Chang CS; Kitamura E; Ren M
Br J Haematol; 2016 Nov; 175(3):542-545. PubMed ID: 27785808
[No Abstract] [Full Text] [Related]
15. Re: Acute myeloid leukemia associated with FGFR1 abnormalities.
Yang JJ; Oh SH; Meyer C; Marschalek R; Park TS
Int J Hematol; 2013 Jul; 98(1):139-40. PubMed ID: 23743951
[No Abstract] [Full Text] [Related]
16. Reply to the letter by Yang et al. RE: acute myeloid leukemia associated with FGFR1 abnormalities.
Kim Y; Lee H; Kim M
Int J Hematol; 2013 Jul; 98(1):141. PubMed ID: 23736983
[No Abstract] [Full Text] [Related]
17. Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia.
Gu TL; Goss VL; Reeves C; Popova L; Nardone J; Macneill J; Walters DK; Wang Y; Rush J; Comb MJ; Druker BJ; Polakiewicz RD
Blood; 2006 Dec; 108(13):4202-4. PubMed ID: 16946300
[TBL] [Abstract][Full Text] [Related]
18. A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment.
Buijs A; van Wijnen M; van den Blink D; van Gijn M; Klein SK
Cancer Genet; 2013 Apr; 206(4):140-4. PubMed ID: 23751892
[TBL] [Abstract][Full Text] [Related]
19. A case of acute myelogenous leukaemia characterised by the BCR-FGFR1 translocation.
Matikas A; Tzannou I; Oikonomopoulou D; Bakiri M
BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23519513
[TBL] [Abstract][Full Text] [Related]
20. Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
Bloomfield CD; Ruppert AS; Mrózek K; Kolitz JE; Moore JO; Mayer RJ; Edwards CG; Sterling LJ; Vardiman JW; Carroll AJ; Pettenati MJ; Stamberg J; Byrd JC; Marcucci G; Larson RA;
Ann Hematol; 2004; 83 Suppl 1():S84-5. PubMed ID: 15124687
[No Abstract] [Full Text] [Related]
[Next] [New Search]
